|
1
|
Chakraborty E and Sarkar D: Emerging
therapies for hepatocellular carcinoma (HCC). Cancers (Basel).
14:27982022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global Cancer Statistics 2020:
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36
Cancers in 185 Countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Teo EK and Fock KM: Hepatocellular
carcinoma: An Asian perspective. Dig Dis. 19:263–268. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Orcutt ST and Anaya DA: Liver resection
and surgical strategies for management of primary liver cancer.
Cancer Control. 25:10732748177446212018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Anwanwan D, Singh SK, Singh S, Saikam V
and Singh R: Challenges in liver cancer and possible treatment
approaches. Biochim Biophys Acta Rev Cancer. 1873:1883142020.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kufel J and Grzechnik P: Small nucleolar
RNAs tell a different tale. Trends Genet. 35:104–117. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Z, Yu H, Yao W, Zhu N, Miao R, Liu
Z, Song X, Xue C, Cai C, Cheng M, et al: RRP9 promotes gemcitabine
resistance in pancreatic cancer via activating AKT signaling
pathway. Cell Commun Signal. 20:1882022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pecoraro A, Pagano M, Russo G and Russo A:
Ribosome biogenesis and cancer: Overview on ribosomal proteins. Int
J Mol Sci. 22:54962021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gee HE, Buffa FM, Camps C, Ramachandran A,
Leek R, Taylor M, Patil M, Sheldon H, Betts G, Homer J, et al: The
small-nucleolar RNAs commonly used for microRNA normalisation
correlate with tumour pathology and prognosis. Br J Cancer.
104:1168–1177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang X, Li Y, Li L, Liu J, Wu M and Ye M:
SnoRNAs are involved in the progression of ulcerative colitis and
colorectal cancer. Dig Liver Dis. 49:545–551. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui L, Nakano K, Obchoei S, Setoguchi K,
Matsumoto M, Yamamoto T, Obika S, Shimada K and Hiraoka N: Small
nucleolar noncoding RNA SNORA23, up-regulated in human pancreatic
ductal adenocarcinoma, regulates expression of spectrin
repeat-containing nuclear envelope 2 to promote growth and
metastasis of xenograft tumors in mice. Gastroenterology.
153:292–306. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Domingo-Relloso A, Huan T, Haack K,
Riffo-Campos AL, Levy D, Fallin MD, Terry MB, Zhang Y, Rhoades DA,
Herreros-Martinez M, et al: DNA methylation and cancer incidence:
Lymphatic-hematopoietic versus solid cancers in the Strong Heart
Study. Clin Epigenetics. 13:432021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zheng J, Zhang T, Guo W, Zhou C, Cui X,
Gao L, Cai C and Xu Y: Integrative analysis of Multi-Omics
identified the prognostic biomarkers in acute myelogenous leukemia.
Front Oncol. 10:5919372020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Z, Jensen MA and Zenklusen JC: A
practical guide to the cancer genome atlas (TCGA). Methods Mol
Biol. 1418:111–141. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kumar AR, L A, Nair B, Mathew B, Sugunan S
and Nath LR: Decoding the Mechanism of drugs of heterocyclic nature
against hepatocellular carcinoma. Anticancer Agents Med Chem.
23:882–893. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Singal AG, Zhang E, Narasimman M, Rich NE,
Waljee AK, Hoshida Y, Yang JD, Reig M, Cabibbo G, Nahon P, et al:
HCC surveillance improves early detection, curative treatment
receipt, and survival in patients with cirrhosis: A meta-analysis.
J Hepatol. 77:128–139. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ayuso C, Rimola J, Vilana R, Burrel M,
Darnell A, García-Criado Á, Bianchi L, Belmonte E, Caparroz C,
Barrufet M, et al: Diagnosis and staging of hepatocellular
carcinoma (HCC): Current guidelines. Eur J Radiol. 101:72–81. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen CL, Chen CJ, Vallon O, Huang ZP, Zhou
H and Qu LH: Genomewide analysis of box C/D and box H/ACA snoRNAs
in Chlamydomonas reinhardtii reveals an extensive organization into
intronic gene clusters. Genetics. 179:21–30. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Romano G, Veneziano D, Acunzo M and Croce
CM: Small non-coding RNA and cancer. Carcinogenesis. 38:485–491.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang D, Zhou J, Gao J, Wu RY, Huang YL,
Jin QW, Chen JS, Tang WZ and Yan LH: Targeting snoRNAs as an
emerging method of therapeutic development for cancer. Am J Cancer
Res. 9:1504–1516. 2019.PubMed/NCBI
|
|
22
|
Yi C, Wan X, Zhang Y, Fu F, Zhao C, Qin R,
Wu H, Li Y and Huang Y: SNORA42 enhances prostate cancer cell
viability, migration and EMT and is correlated with prostate cancer
poor prognosis. Int J Biochem Cell Biol. 102:138–150. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Okugawa Y, Toiyama Y, Toden S, Mitoma H,
Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A:
Clinical significance of SNORA42 as an oncogene and a prognostic
biomarker in colorectal cancer. Gut. 66:107–117. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou
W and Dong JT: Implication of snoRNA U50 in human breast cancer. J
Genet Genomics. 36:447–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wan R, Bai L, Cai C, Ya W, Jiang J, Hu C,
Chen Q, Zhao B and Li Y: Discovery of tumor immune
infiltration-related snoRNAs for predicting tumor immune
microenvironment status and prognosis in lung adenocarcinoma.
Comput Struct Biotechnol J. 19:6386–6399. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Łuczkowska K, Kulig P, Baumert B and
Machaliński B: The evidence that 25(OH)D3 and VK2 MK-7 vitamins
influence the proliferative potential and gene expression profiles
of multiple myeloma cells and the development of resistance to
bortezomib. Nutrients. 14:51902022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang F, Qu H, Lin Q, Yang Y, Ruan X,
Zhang B, Liu Y, Yu C, Zhang H, Fang X and Hao X: Molecular
biomarkers screened by next-generation RNA sequencing for
non-sentinel lymph node status prediction in breast cancer patients
with metastatic sentinel lymph nodes. World J Surg Oncol.
13:2582015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tosar JP, García-Silva MR and Cayota A:
Circulating SNORD57 rather than piR-54265 is a promising biomarker
for colorectal cancer: Common pitfalls in the study of somatic
piRNAs in cancer. RNA. 27:403–410. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang C, Zhang H, Zhang L, Zhu AX, Bernards
R, Qin W and Wang C: Evolving therapeutic landscape of advanced
hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol.
20:203–222. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang L, Mo H, Jiang Y, Wang Y, Sun L, Yao
B, Chen T, Liu R, Li Q, Liu Q and Yin G: MicroRNA-519c-3p promotes
tumor growth and metastasis of hepatocellular carcinoma by
targeting BTG3. Biomed Pharmacother. 118:1092672019. View Article : Google Scholar : PubMed/NCBI
|
